SANTORO, Armando
SANTORO, Armando
Dipartimento Scienze Biomediche
. The level of HER2/neu amplification may have a correlation with some relevant histopathologcal features of early stage breast cancer
2006-01-01 Gullo, G; Bettio, D; Masci, G; Torri, V; Di Tommaso, L; Banna, G; Santoro, A
18F-FDG PET and CT scan in the pre-operative evaluation of colorectal liver metastases treated with chemotherapy
2006-01-01 Rimassa, L.; Chiti, A.; Carnaghi, C.; Doci, R.; Torzilli, G; Zuradelli, M.; Tondulli, L.; Pressiani, T.; Lutman, F. R.; Tronconi, M. C.; Santoro, A.
18F-FDG pet does not improve contrast enhanced CT scan sensitivity in the evaluation of liver metastases after chemotherapy
2006-01-01 Carnaghi, Carlo; Chiti, Arturo; Rimassa, Lorenza; Zuradelli, Monica; Tondulli, Luca; Torzilli, G; Doci, Roberto; Tronconi Maria, Chiara; Pressiani, Tiziana; Santoro, Armando
48P The relationship among bowel FDG-PET uptake, pathological complete response, and the influence of eating and exercise habits in breast cancer patients undergoing neoadjuvant chemotherapy
2022-01-01 Tiberio, P.; Antunovic, L.; Gaudio, M.; Viganò, A.; Pastore, M.; Miggiano, C.; Jacobs, F.; Benvenuti, C.; Farina, E.; Chiti, A.; Santoro, A.; De Sanctis, R.
A Case of Pulmonary Sarcoidosis during First-Line Targeted Therapy with Dabrafenib Plus Trametinib in BRAF V600E-Mutated Metastatic Melanoma
2022-01-01 Tronconi, Maria Chiara; Marinello, Arianna; Solferino, Alessandra; Grimaudo, Susanna; Ciccarelli, Michele; Manara, Sofia; Cozzaglio, Luca; Mancini, Luca; Borroni, Riccardo; Santoro, Armando
A circulating miRNA signature to implement diagnostic imaging analysis in young early-stage breast cancer patients
2016-01-01 Paladini, L; Bottai, G; Raschioni, C; Sagona, A; Errico, V; Torrisi, R; Canavese, G; Gatzmeier, W; Barbieri, E; Rubino, A; Rossetti, C; Eboli, M; Malerba, P; Scorsetti, M; Antunovic, L; Alloisio, M; Santoro, A; Testori, A; Tinterri, C; Santarpia, L
A monocentric retrospective analysis of TILs and AR as hints for prognosis definition in TNBC
2018-01-01 Losurdo, A; De Sanctis, R; Fernandes, B; Errico, V; Sagona, A; Masci, G; Zuradelli, M; Agostinetto, E; Torrisi, R; Gatzemeier, W; Testori, A; Roncalli, M; Alloisio, M; Tinterri, C; Santoro, A
A multi-center real-life prospective study of axicabtagene ciloleucel versus tisagenlecleucel toxicity and outcomes in Large B-Cell Lymphomas
2024-01-01 Stella, Federico; Chiappella, Annalisa; Casadei, Beatrice; Bramanti, Stefania; Ljevar, Silva; Chiusolo, Patrizia; Di Rocco, Alice; Tisi, Maria Chiara; Carrabba, Matteo Giovanni; Cutini, Ilaria; Martino, Massimo; Dodero, Anna; Bonifazi, Francesca; Santoro, Armando; Sora, Federica; Botto, Barbara; Barbui, Anna Maria; Russo, Domenico; Musso, Maurizio; Grillo, Giovanni; Krampera, Mauro; Olivieri, Jacopo; Ladetto, Marco; Cavallo, Federica; Massaia, Massimo; Arcaini, Luca; Pennisi, Martina; Zinzani, Pier Luigi; Miceli, Rosalba; Corradini, Paolo
A new human cell line, PDSS-26, from poorly differentiated synovial sarcoma, with unique chromosomal anomalies
2003-01-01 Berardi, Ac; Parafioriti, A; Barisani, D; Papp, B; Armiraglio, E; Martinoli, M; Dalpra, L; Santoro, A
A PHASE 1 SAFETY STUDY OF ONCOFID-P-B ADMINISTERED FOR 12 CONSECUTIVE WEEKS IN BCG UNRESPONSIVE/INTOLERANT PATIENTS WITH BLADDER CARCINOMA IN SITU (CIS): PRELIMINARY RESULTS
2019-01-01 Hurle, R; Lazzeri, M; Guazzoni, G; Colombo, P; Santoro, A; De Cobelli, O; Di Trapani, E; Nohales, G; Carlos, L; Duran-Merino, R
A phase I clinical and pharmacokinetic study evaluating vinflumine in combination with epirubicin as first-line treatment in metastatic breast cancer
2014-01-01 Chan, S; Campone, M; Santoro, A; Conte, P F; Bostnavaron, M; Nguyen, L
A phase Ib study of the combination of naporafenib with rineterkib or trametinib in patients with advanced and metastatic KRAS- or BRAF-mutant non-small cell lung cancer
2024-01-01 Planchard, David; Wolf, Jürgen; Solomon, Benjamin; Sebastian, Martin; Wermke, Martin; Heist, Rebecca S; Sun, Jong-Mu; Min Kim, Tae; Reguart, Noemi; Sanmamed, Miguel F; Felip, Enriqueta; Garrido, Pilar; Santoro, Armando; Bootle, Douglas; Couillebault, Xuân-Mai; Gaur, Anil; Mueller, Christina; Poggio, Teresa; Yang, Jie; Moschetta, Michele; Dooms, Christophe
A phase Ib/II trial of capmatinib plus spartalizumab vs. spartalizumab alone in patients with pretreated hepatocellular carcinoma
2024-01-01 Santoro, Armando; Assenat, Eric; Yau, Thomas; Delord, Jean-Pierre; Maur, Michela; Knox, Jennifer; Cattan, Stephane; Lee, Kyung-Hun; Del Conte, Gianluca; Springfeld, Christoph; Leo, Elisa; Xyrafas, Alexandros; Fairchild, Lauren; Mardjuadi, Feby; Chan, Stephen L.
A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma
2018-01-01 Gadducci, A; Grosso, F; Scambia, G; Raspagliesi, F; Colombo, N; Grignani, G; Casali, P; Sanfilippo, R; Buonadonna, A; Santoro, A; Bruzzone, M; Artioli, G; Lorusso, D; Biagioli, E; Fossati, R; Galli, F; Negri, E; Rulli, E; Torri, V; D’Incalci, M
A Phase II Randomized Dose Escalation Trial of Sorafenib in Patients with Advanced Hepatocellular Carcinoma
2013-01-01 Rimassa, L; Pressiani, T; Boni, C; Carnaghi, C; Rota Caremoli, E; Fagiuoli, S; Foa, P; Salvagni, S; Cortesi, E; Tronconi, Mc; Personeni, N; Bozzarelli, S; Banzi, Mc; Fanello, S; Lutman, Fr; Giordano, L; Santoro, A
A phase II randomized multicenter trial of gefitinib plus FOLFIRI and FOLFIRI alone in patients with metastatic colorectal cancer
2008-01-01 Santoro, A; Comandone, A; Rimassa, L; Granetti, C; Lorusso, V; Oliva, C; Ronzoni, M; Siena, S; Zuradelli, M; Mari, E; Pressiani, T; Carnaghi, C
A Phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small cell lung cancer.
2014-01-01 Novello, S; Besse, B; Felip, E; Barlesi, F; Mazieres, J; Zalcman, G; Von Pawel, J; Reck, M; Cappuzzo, F; Ferry, D; Carcereny, E; Santoro, A; Garcia-Ribas, I; Scagliotti, G; Soria, J C
A phase II study of the combination of gemcitabine and imatinib mesylate in pemetrexed-pretreated patients with malignant pleural mesothelioma
2020-01-01 Zucali, Pa; Perrino, M; de Vincenzo, F; Giordano, L; Cordua, N; D’Antonio, F; Santoro, A
A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis
2013-01-01 Santoro, A; Simonelli, M; Rodriguez-Lope, C; Zucali, P; Camacho, Lh; Granito, A; Senzer, N; Rimassa, L; Abbadessa, G; Schwartz, B; Lamar, M; Savage, Re; Bruix, J
A pilot analysis of headache disorders in breast cancer patients
2022-01-01 De Sanctis, Rita; Viganò, Alessandro; Pindilli, Sebastiano; Torrisi, Rosalba; Santoro, Armando
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| . The level of HER2/neu amplification may have a correlation with some relevant histopathologcal features of early stage breast cancer | 1-gen-2006 | Gullo, G; Bettio, D; Masci, G; Torri, V; Di Tommaso, L; Banna, G; Santoro, A | |
| 18F-FDG PET and CT scan in the pre-operative evaluation of colorectal liver metastases treated with chemotherapy | 1-gen-2006 | Rimassa, L.; Chiti, A.; Carnaghi, C.; Doci, R.; Torzilli, G; Zuradelli, M.; Tondulli, L.; Pressiani, T.; Lutman, F. R.; Tronconi, M. C.; Santoro, A. | |
| 18F-FDG pet does not improve contrast enhanced CT scan sensitivity in the evaluation of liver metastases after chemotherapy | 1-gen-2006 | Carnaghi, Carlo; Chiti, Arturo; Rimassa, Lorenza; Zuradelli, Monica; Tondulli, Luca; Torzilli, G; Doci, Roberto; Tronconi Maria, Chiara; Pressiani, Tiziana; Santoro, Armando | |
| 48P The relationship among bowel FDG-PET uptake, pathological complete response, and the influence of eating and exercise habits in breast cancer patients undergoing neoadjuvant chemotherapy | 1-gen-2022 | Tiberio, P.; Antunovic, L.; Gaudio, M.; Viganò, A.; Pastore, M.; Miggiano, C.; Jacobs, F.; Benvenuti, C.; Farina, E.; Chiti, A.; Santoro, A.; De Sanctis, R. | |
| A Case of Pulmonary Sarcoidosis during First-Line Targeted Therapy with Dabrafenib Plus Trametinib in BRAF V600E-Mutated Metastatic Melanoma | 1-gen-2022 | Tronconi, Maria Chiara; Marinello, Arianna; Solferino, Alessandra; Grimaudo, Susanna; Ciccarelli, Michele; Manara, Sofia; Cozzaglio, Luca; Mancini, Luca; Borroni, Riccardo; Santoro, Armando | |
| A circulating miRNA signature to implement diagnostic imaging analysis in young early-stage breast cancer patients | 1-gen-2016 | Paladini, L; Bottai, G; Raschioni, C; Sagona, A; Errico, V; Torrisi, R; Canavese, G; Gatzmeier, W; Barbieri, E; Rubino, A; Rossetti, C; Eboli, M; Malerba, P; Scorsetti, M; Antunovic, L; Alloisio, M; Santoro, A; Testori, A; Tinterri, C; Santarpia, L | |
| A monocentric retrospective analysis of TILs and AR as hints for prognosis definition in TNBC | 1-gen-2018 | Losurdo, A; De Sanctis, R; Fernandes, B; Errico, V; Sagona, A; Masci, G; Zuradelli, M; Agostinetto, E; Torrisi, R; Gatzemeier, W; Testori, A; Roncalli, M; Alloisio, M; Tinterri, C; Santoro, A | |
| A multi-center real-life prospective study of axicabtagene ciloleucel versus tisagenlecleucel toxicity and outcomes in Large B-Cell Lymphomas | 1-gen-2024 | Stella, Federico; Chiappella, Annalisa; Casadei, Beatrice; Bramanti, Stefania; Ljevar, Silva; Chiusolo, Patrizia; Di Rocco, Alice; Tisi, Maria Chiara; Carrabba, Matteo Giovanni; Cutini, Ilaria; Martino, Massimo; Dodero, Anna; Bonifazi, Francesca; Santoro, Armando; Sora, Federica; Botto, Barbara; Barbui, Anna Maria; Russo, Domenico; Musso, Maurizio; Grillo, Giovanni; Krampera, Mauro; Olivieri, Jacopo; Ladetto, Marco; Cavallo, Federica; Massaia, Massimo; Arcaini, Luca; Pennisi, Martina; Zinzani, Pier Luigi; Miceli, Rosalba; Corradini, Paolo | |
| A new human cell line, PDSS-26, from poorly differentiated synovial sarcoma, with unique chromosomal anomalies | 1-gen-2003 | Berardi, Ac; Parafioriti, A; Barisani, D; Papp, B; Armiraglio, E; Martinoli, M; Dalpra, L; Santoro, A | |
| A PHASE 1 SAFETY STUDY OF ONCOFID-P-B ADMINISTERED FOR 12 CONSECUTIVE WEEKS IN BCG UNRESPONSIVE/INTOLERANT PATIENTS WITH BLADDER CARCINOMA IN SITU (CIS): PRELIMINARY RESULTS | 1-gen-2019 | Hurle, R; Lazzeri, M; Guazzoni, G; Colombo, P; Santoro, A; De Cobelli, O; Di Trapani, E; Nohales, G; Carlos, L; Duran-Merino, R | |
| A phase I clinical and pharmacokinetic study evaluating vinflumine in combination with epirubicin as first-line treatment in metastatic breast cancer | 1-gen-2014 | Chan, S; Campone, M; Santoro, A; Conte, P F; Bostnavaron, M; Nguyen, L | |
| A phase Ib study of the combination of naporafenib with rineterkib or trametinib in patients with advanced and metastatic KRAS- or BRAF-mutant non-small cell lung cancer | 1-gen-2024 | Planchard, David; Wolf, Jürgen; Solomon, Benjamin; Sebastian, Martin; Wermke, Martin; Heist, Rebecca S; Sun, Jong-Mu; Min Kim, Tae; Reguart, Noemi; Sanmamed, Miguel F; Felip, Enriqueta; Garrido, Pilar; Santoro, Armando; Bootle, Douglas; Couillebault, Xuân-Mai; Gaur, Anil; Mueller, Christina; Poggio, Teresa; Yang, Jie; Moschetta, Michele; Dooms, Christophe | |
| A phase Ib/II trial of capmatinib plus spartalizumab vs. spartalizumab alone in patients with pretreated hepatocellular carcinoma | 1-gen-2024 | Santoro, Armando; Assenat, Eric; Yau, Thomas; Delord, Jean-Pierre; Maur, Michela; Knox, Jennifer; Cattan, Stephane; Lee, Kyung-Hun; Del Conte, Gianluca; Springfeld, Christoph; Leo, Elisa; Xyrafas, Alexandros; Fairchild, Lauren; Mardjuadi, Feby; Chan, Stephen L. | |
| A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma | 1-gen-2018 | Gadducci, A; Grosso, F; Scambia, G; Raspagliesi, F; Colombo, N; Grignani, G; Casali, P; Sanfilippo, R; Buonadonna, A; Santoro, A; Bruzzone, M; Artioli, G; Lorusso, D; Biagioli, E; Fossati, R; Galli, F; Negri, E; Rulli, E; Torri, V; D’Incalci, M | |
| A Phase II Randomized Dose Escalation Trial of Sorafenib in Patients with Advanced Hepatocellular Carcinoma | 1-gen-2013 | Rimassa, L; Pressiani, T; Boni, C; Carnaghi, C; Rota Caremoli, E; Fagiuoli, S; Foa, P; Salvagni, S; Cortesi, E; Tronconi, Mc; Personeni, N; Bozzarelli, S; Banzi, Mc; Fanello, S; Lutman, Fr; Giordano, L; Santoro, A | |
| A phase II randomized multicenter trial of gefitinib plus FOLFIRI and FOLFIRI alone in patients with metastatic colorectal cancer | 1-gen-2008 | Santoro, A; Comandone, A; Rimassa, L; Granetti, C; Lorusso, V; Oliva, C; Ronzoni, M; Siena, S; Zuradelli, M; Mari, E; Pressiani, T; Carnaghi, C | |
| A Phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small cell lung cancer. | 1-gen-2014 | Novello, S; Besse, B; Felip, E; Barlesi, F; Mazieres, J; Zalcman, G; Von Pawel, J; Reck, M; Cappuzzo, F; Ferry, D; Carcereny, E; Santoro, A; Garcia-Ribas, I; Scagliotti, G; Soria, J C | |
| A phase II study of the combination of gemcitabine and imatinib mesylate in pemetrexed-pretreated patients with malignant pleural mesothelioma | 1-gen-2020 | Zucali, Pa; Perrino, M; de Vincenzo, F; Giordano, L; Cordua, N; D’Antonio, F; Santoro, A | |
| A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis | 1-gen-2013 | Santoro, A; Simonelli, M; Rodriguez-Lope, C; Zucali, P; Camacho, Lh; Granito, A; Senzer, N; Rimassa, L; Abbadessa, G; Schwartz, B; Lamar, M; Savage, Re; Bruix, J | |
| A pilot analysis of headache disorders in breast cancer patients | 1-gen-2022 | De Sanctis, Rita; Viganò, Alessandro; Pindilli, Sebastiano; Torrisi, Rosalba; Santoro, Armando |